Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis
J. Brown, Osama Mohamad, Wendy Seiferheld, H. Sandler et al.
Journal
The Lancet
Topics
Prostate Cancer Diagnosis and Treatment
article
Hormone therapy use and duration with postoperative radiotherapy for recurrent prostate cancer: an individual patient data meta-analysis
J. Brown, Osama Mohamad, Wendy Seiferheld, H. Sandler, J GARCIA, Luca Valle, Matthew B. Rettig, Yilun Sun, Jason A. Efstathiou, Meryem Brihoum, Angela Jia, Wayne Brisbane, Michael L. Steinberg, Soumyajit Roy, Kekoa Taparra, J. Dignam, Adam Singer, Tahmineh Romero Kalbasi, Sylvie Chabaud, Scott Eggener, Ting Martin Ma, A. Pollack, Jonathan E Shoag, Nicholas G Nickols, Pascal Pommier, Paul L Nguyen, Paul Sargos, Amar U Kishan, Robert E Reiter, Daniel E Spratt, Nicholas G Zaorsky, Christopher C Parker
article en
Abstract
No abstract available for this paper.
Publication Tag
The LancetVol. 407(10533)
Institutions
Cedars-Sinai Medical Center (US), Brigham and Women's Hospital (US), Royal Marsden NHS Foundation Trust (GB), Harvard University (US), University of California, Los Angeles (US), University of Washington (US), Massachusetts General Hospital (US), MRC Clinical Trials Unit at UCL (GB), American University of Beirut Medical Center (LB), Centre Léon Bérard (FR), Dana-Farber Cancer Institute (US), University Hospitals Seidman Cancer Center (US), Institut Bergonié (FR), UniCancer Group (FR), VA Greater Los Angeles Healthcare System (US), Sylvester Comprehensive Cancer Center (US), Dana-Farber Brigham Cancer Center (US), NRG Oncology (US), University College London (GB), Case Western Reserve University (US), American University of Beirut (LB)